Patents by Inventor Khalid El-Sayed

Khalid El-Sayed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isothiocyanatostilbenes as a novel method and product for treating cancer
    Patent number: 10980765
    Abstract: Products and methods for treating cancer in a human patient comprising administering to the patient therapeutically effective amount of a first pharmaceutically active agent, wherein the first pharmaceutically active agent is one of an isothiocyanatostilbene and a pharmacologically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof, or a combination thereof.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: April 20, 2021
    Assignees: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY, BOARD OF SUPERVISORS FOR THE UNIVERSITY OF LOUISIA
    Inventors: Alana Lea Gray, James Cardelli, David Thomas Coleman, Khalid El-Sayed, Mohamed M. Mohyeldin
  • Methods for treating c-Met-dependent cancers
    Patent number: 10959968
    Abstract: A method of treating cancer or a precancer condition in a mammal comprising administering a therapeutically effective amount of a homovanillyl sinapate analog or pharmacologically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof, or a combination thereof.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: March 30, 2021
    Assignee: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY
    Inventors: James Allen Cardelli, Ana-Maria Dragoi, Khalid El-Sayed, Mohamed M. Mohyeldin
  • METHODS FOR TREATING C-MET-DEPENDENT CANCERS
    Publication number: 20190328690
    Abstract: A method of treating cancer or a precancer condition in a mammal comprising administering a therapeutically effective amount of a homovanillyl sinapate analog or pharmacologically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof, or a combination thereof.
    Type: Application
    Filed: January 13, 2017
    Publication date: October 31, 2019
    Inventors: James Allen CARDELLI, Ana-Maria DRAGOI, Khalid EL-SAYED, Mohamed M. MOHYELDIN
  • ISOTHIOCYANATOSTILBENES AS A NOVEL METHOD AND PRODUCT FOR TREATING CANCER
    Publication number: 20190000791
    Abstract: Products and methods for treating cancer in a human patient comprising administering to the patient therapeutically effective amount of a first pharmaceutically active agent, wherein the first pharmaceutically active agent is one of an isothiocyanatostilbene and a pharmacologically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof, or a combination thereof.
    Type: Application
    Filed: August 15, 2016
    Publication date: January 3, 2019
    Inventors: Alana Lea GRAY, James CARDELLI, David Thomas COLEMAN, Khalid EL-SAYED, Mohamed M. MOHYELDIN
  • Manzamines in the treatment of infectious disease
    Publication number: 20050159400
    Abstract: A method of treating an infectious disease or condition in a subject in need of such treatment is disclosed. The method comprises administering to a subject an effective amount of a manzamine, manzamine derivative or analog or an optical isomer or racemate or tautomer thereof or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: January 5, 2005
    Publication date: July 21, 2005
    Inventors: Mark Hamann, Khalid El-Sayed
  • Manzamines for treatment of drug resistant infection
    Patent number: 6900195
    Abstract: A method of treating an infectious disease or condition in a subject in need of such treatment is disclosed. The method comprises administering to a subject an effective amount of a manzamine, manzamine derivative or analog or an optical isomer or racemate or tautomer thereof or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 29, 2001
    Date of Patent: May 31, 2005
    Assignee: The University of Mississippi
    Inventors: Mark T. Hamann, Khalid El-Sayed
  • Manzamines for treatment of drug resistant infection
    Publication number: 20040019029
    Abstract: A method of treating an infectious disease or condition in a subject in need of such treatment is disclosed. The method comprises administering to a subject an effective amount of a manzamine, manzamine derivative or analog or an optical isomer or racemate or tautomer thereof or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 22, 2003
    Publication date: January 29, 2004
    Inventors: Mark T. Hamann, Khalid El-Sayed